UBS


27/01/21 -"Strong Q4 20 and FY 2020 figures which were clearly above consensus and our expectations. UBS was a winner of the COVID-19 turmoil in 2020, especially the Investment Bank. We have therefore upgraded ..."

Pages
59
Language
English
Published on
27/01/21
You may also be interested by these reports :
17/11/26
As announced in our post-release comments, we have downgraded our earnings projections for 2026 and 2027. On the other hand, we have decided to ...

16/11/26
We have updated our earnings projections following the release of the third quarter results. This has translated into minor changes in 2026. However, ...

13/11/26
KBC posted good Q3 results despite a 3% pre-tax miss, driven by NII (inflation-linked bond normalisation), fees, costs and LLPs from two unrelated ...

12/11/26
Third-quarter results showed an ongoing, albeit delayed, recovery in profitability. As a result, management downgraded its full-year profit guidance. ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO